HI
PTCT icon

Harbour Investments’s PTC Therapeutics PTCT Stock Holding History

Harbour Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38K Hold
35
– – ﹤0.01% 3863
2025
Q4 		$2.66K Hold
35
– – ﹤0.01% 3232
2025
Q3 		$2.15K Hold
35
– – ﹤0.01% 3246
2025
Q2 		$1.71K Hold
35
– – ﹤0.01% 3173
2025
Q1 		$1.78K Hold
35
– – ﹤0.01% 3112
2024
Q4 		$1.58K Hold
35
– – ﹤0.01% 3064
2024
Q3 		$1.3K Buy
+35
New +$1.17K ﹤0.01% 3039

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Harbour Investments's PTCT Position: Q1 2026 in Review

Harbour Investments held its PTC Therapeutics (PTCT) position steady in Q1 2026 at 35 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #3863.

Harbour Investments first reported a position in PTCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.66K in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Harbour Investments held 35 shares of PTC Therapeutics worth $2.38K as of Q1 2026.
  • Harbour Investments left its PTC Therapeutics share count unchanged in Q1 2026.
  • PTC Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3863 holding.
  • Harbour Investments first reported a position in PTC Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Harbour Investments's PTC Therapeutics position peaked at $2.66K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.